Blood Culture Test Devices Market 2019 Global Size, Share, Emerging Trends, Company Profiles with Growth Factors by Forecast 2026 | BioMerieux, BD, Cepheid, Nanosphere, Bruker, Alere, Beckman Coulter

In this report, the United States Blood Culture Test Devices market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2026, growing at a CAGR of XX% between 2019 and 2026.

The blood culture test is usually performed in a laboratory to detect the infection caused by bacteria in the blood and determine the cause. The technique involves the extraction of a blood sample from the vein in the arm by using a hypodermic needle or finger prick. Infection in the blood is mostly caused by bacteria but also sometimes yeast, fungi, and viruses. For example, blood tests can be used to detect the causative organisms in a medical condition such as puerperal fever, pneumonia, neonatal epiglottitis, pelvic inflammatory disease, sepsis, and fever.

Download Free Sample Copy of Blood Culture Test Devices Market Report from Industry Experts @ https://www.stratagemmarketinsights.com/sample/8787

Rising cases of bloodstream infection in the U.S region is projected to propel the regional market growth. According to the World Health Organization (WHO), nearly 250,000 cases of BSIs occur in the U.S. annually, and among them, around 80,000 patients in ICUs suffer from catheter-related BSIs. Therefore, growing cases of bloodstream infections in the region are projected to foster market growth of the United States blood culture test devices. Moreover, increasing approval of advanced blood tests by the FDA is also projected to augment the market growth over the forecast period. For instance, in October 2017, the U.S. Food and Drug Administration approved the cobas Zika test, a qualitative nucleic acid test for identifying Zika virus RNA in individual plasma specimens extracted from volunteer donors of whole blood and blood components, and from living organ donors. It is intended for use by blood collection establishments to detect the Zika virus in blood donations, not for the individual diagnosis of Zika virus infection.

The market growth of U.S blood culture test devices is also attributed to rising healthcare expenditure by the U.S government. For instance, according to USAspending.gov, in 2019, the government of the U.S spent $4.45 trillion in the healthcare industry. This factor is also expected to fuel the regional market growth of blood culture test devices. Moreover, rising investment in research and development by major players engaged in the blood culture testing devices is further expected to fuel the market growth. For instance, in 2016, Becton, Dickinson and Company, a leading blood culture testing product provider, invested around USD 1,430 million in R&D.

Key Developments:

• In June 2017, bioMérieux has received 510(k) clearance from the Food and Drug Administration for the BacT/Alert Virtuo, a fully automated blood culture microbial detection system

• In October 2018, Bruker introduces new diagnostic solutions for rapid and cost-effective microbial identification and antibiotic resistance testing from positive blood cultures – called the integrated Bologna Workflow. Bruker also launched additional molecular assays for comprehensive and fast invasive fungal disease (IFD) testing in blood

• In May 2018, Roche Diagnostics received approval for its Ammonia II assay, an enzymatic test for the determination of ammonia in human plasma, running on Roche's Cobas c systems

Get More Information on Blood Culture Test Devices Market Research Report - Global Forecast till 2026 @ https://www.stratagemmarketinsights.com/quiry/8787

Geographically, this report splits the United States market into seven regions:
--The West
--Southwest
--The Middle Atlantic
--New England
--The South
--The Midwest
with sales (volume), revenue (value), market share and growth rate of Blood Culture Test Devices in these regions, from 2014 to 2026 (forecast).

United States Blood Culture Test Devices market competition by top manufacturers/players, with Blood Culture Test Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
--BioMerieux
--BD
--Cepheid
--Nanosphere
--Bruker
--Alere
--Beckman Coulter
--IRIDICA (Abbott)
--Roche

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
--Manual Type
--Automate Type

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Blood Culture Test Devices for each application, including
--Hospital
--Reference Laboratory
--Clinical Laboratory
--Academic Research Institute

If you have any special requirements, please let us know and we will offer you the report as you want.

Get Impressive Discount: https://www.stratagemmarketinsights.com/discount/8787

Get in Touch:

Mr. Shah
Stratagem Market Insights
Tel: +1-415-871-0703
Email: sales@stratagemmarketinsights.com
Visit Here: https://deep-research-report.blogspot.com/

About Us:

Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with an cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide. Our reports cover various end-use industries such as Aerospace and Defense, Agriculture, Food and Beverages, Automotive, Chemicals and Materials, Consumer Goods and Retail, Electronics, Energy, Mining, and Utilities, Pharmaceuticals, Manufacturing and Construction, Services, and Healthcare, and ICT.

This release was published on openPR.